The firm plans to use the proceeds to support its commercialization and R&D activities as well as for working capital and general corporate purposes.

According to Statifacts, the global Immunoassay market size is calculated at USD 32,820 million in 2024 and is expected to ...

PORTLAND, IA, UNITED STATES, February 13, 2025 /EINPresswire / -- LFIA based rapid test market is anticipated to exhibit growth owing to increase in incidence of infectious disease, rise in awareness ...

Archimed has invested heavily in the invitro diagnostics sector in recent years. Before acquiring Diesse in July 2019, the healthcare-focused private equity firm bought Eurolyser in February of that ...

Archimed sold Diesse for €125 million in January, after spending six years expanding the company through internationalization ...

A research team at UCLA has developed a deep learning-powered chemiluminescence vertical flow assay (CL-VFA) that brings ...

The global immunodiagnostics market size is calculated at USD 24.20 billion in 2025 and is expected to reach around USD 70.9 ...

The test, which runs on the Swiss company's high-throughput MosaiQ System, detects 15 different autoantibodies.

Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. Lateral flow immunoassay (LFI) serves as a widely used POCT ...

Key Laboratory for Ultrafine Materials of Ministry of Education, School of Materials Science and Engineering, East China University of Science and Technology, Shanghai 200237, China ...